Publication: De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity.
| dc.contributor.author | Hnízda, Aleš | |
| dc.contributor.author | Martinez-Delgado, Beatriz | |
| dc.contributor.author | Sánchez-Ponce, Diana | |
| dc.contributor.author | Alonso, Javier | |
| dc.contributor.author | Amiel, Jeanne | |
| dc.contributor.author | Attie-Bitach, Tania | |
| dc.contributor.author | Bada-Navarro, Ariadna | |
| dc.contributor.author | Baladron-Jimenez, Beatriz Isabel | |
| dc.contributor.author | Bermejo-Sanchez, Eva | |
| dc.contributor.author | Brinsa, Vítězslav | |
| dc.contributor.author | Buková, Ivana | |
| dc.contributor.author | Cazorla-Calleja, Rosario | |
| dc.contributor.author | Červenková, Sylvie | |
| dc.contributor.author | Chow, Shanshan | |
| dc.contributor.author | Dušek, Petr | |
| dc.contributor.author | Fedosieieva, Olha | |
| dc.contributor.author | Fernandez-Prieto, Marta | |
| dc.contributor.author | Ghosh, Sourav | |
| dc.contributor.author | Gomez-Mariano, Gema Maria | |
| dc.contributor.author | Gřegořová, Andrea | |
| dc.contributor.author | Hamilton, Mark James | |
| dc.contributor.author | Hartmannová, Hana | |
| dc.contributor.author | Hernandez-SanMiguel, Esther | |
| dc.contributor.author | Herrero-Matesanz, Marina | |
| dc.contributor.author | Hodaňová, Kateřina | |
| dc.contributor.author | Kádek, Alan | |
| dc.contributor.author | Kerkhof, Jennifer | |
| dc.contributor.author | Kleefstra, Tjitske | |
| dc.contributor.author | Lacombe, Didier | |
| dc.contributor.author | Levy, Michael A | |
| dc.contributor.author | Lopez-Martin, Estrella | |
| dc.contributor.author | Lyse, Ruaud | |
| dc.contributor.author | Man, Petr | |
| dc.contributor.author | Marin-Reina, Purificacion | |
| dc.contributor.author | Macnamara, Ellen F | |
| dc.contributor.author | McConkey, Haley | |
| dc.contributor.author | Melenovská, Petra | |
| dc.contributor.author | Mirela Mielu, Lidia | |
| dc.contributor.author | Moore, David | |
| dc.contributor.author | Steiner Mrázová, Lenka | |
| dc.contributor.author | Musilová, Karolína | |
| dc.contributor.author | Neffeová, Kristýna | |
| dc.contributor.author | Nickl, Petr | |
| dc.contributor.author | Pajuelo Reguera, David | |
| dc.contributor.author | Pavlíková, Martina | |
| dc.contributor.author | Pavlovičová, Lea | |
| dc.contributor.author | Posada De la Paz, Manuel | |
| dc.contributor.author | Procházka, Jan | |
| dc.contributor.author | Pysanenko, Kateryna | |
| dc.contributor.author | Ramos-Del Saz, Sheila | |
| dc.contributor.author | Rots, Dmitrijs | |
| dc.contributor.author | Rzasa, Jessica | |
| dc.contributor.author | Sedláček, Radislav | |
| dc.contributor.author | Stránecký, Viktor | |
| dc.contributor.author | Špoutil, František | |
| dc.contributor.author | Tedder, Matthew L | |
| dc.contributor.author | Thompson, Louise | |
| dc.contributor.author | Tifft, Cynthia J | |
| dc.contributor.author | Tran Mau-Them, Frederic | |
| dc.contributor.author | Trešlová, Helena | |
| dc.contributor.author | Vitobello, Antonio | |
| dc.contributor.author | Hilton, Sarah | |
| dc.contributor.author | Campbell, Christopher | |
| dc.contributor.author | Banka, Siddharth | |
| dc.contributor.author | Jirák, Daniel | |
| dc.contributor.author | Sadikovic, Bekim | |
| dc.contributor.author | Sikora, Jakub | |
| dc.contributor.author | Kmoch, Stanislav | |
| dc.contributor.author | Barrero, Maria J | |
| dc.contributor.author | Nosková, Lenka | |
| dc.contributor.funder | Unión Europea. Comisión Europea | |
| dc.contributor.funder | Fundación Inocente-Inocente | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades (España) | |
| dc.date.accessioned | 2026-11-03T13:38:31Z | |
| dc.date.available | 2026-11-03T13:38:31Z | |
| dc.date.issued | 2026-07-01 | |
| dc.description.abstract | EHMT1 and EHMT2 genes encode human euchromatin histone lysine methyltransferase 1 and 2 (EHMT1 alias GLP; EHMT2 alias G9a) that form heteromeric GLP/G9a complexes with essential roles in epigenetic regulation of gene expression. While EHMT1 haploinsufficiency has been established as the cause of Kleefstra syndrome 1, the pathogenesis of G9a dysfunction in human disease remains largely unknown. We identified seven de novo EHMT2 variants in patients with clinical presentation, episignatures, histone modifications and transcriptomic profiles similar to those of Kleefstra syndrome 1. In vitro studies reveal that these variants encode for structurally stable G9a proteins that are catalytically incompetent due to aberrant interactions either with histone H3 tail or with S-adenosylmethionine. Heterozygous mice carrying a patient-derived variant exhibit growth retardation, facial/skull dysmorphia and aberrant behavior. Here we report pathogenic EHMT2 variants that likely exert dominant-negative effect on GLP/G9a complexes and thus genocopy the EHMT1 haploinsufficiency via a distinct molecular mechanism, defining an autosomal dominant EHMT2-related Kleefstra syndrome. | |
| dc.description.peerreviewed | Sí | |
| dc.description.sponsorship | This work was supported from the project MULTIOMICS_CZ (Program Johannes Amos Comenius, Ministry of Education, Youth and Sports of the Czech Republic, ID Project CZ.02.01.01/00/23_020/0008540) – Co-funded by the European Union. L.N., A.H., and J.S. were supported by the project National Institute for Neurological Research (Program EXCELES, ID Project No. LX22NPO5107) - Funded by the European Union – Next Generation EU and by institutional program UNCE/MED/007 of Charles University in Prague. A.H. was funded from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 101003406 (HIPPOSTRUCT). AH, AK, VB and LN were funded by the grant 26-21355S from the Czech Science Foundation. L.N., J.S. and S.K. were supported by grants NU23-07-00281 and NW24-04-00067 from the Ministry of Health of the Czech Republic. L.N., V.S. and S.K thank the National Center for Medical Genomics (LM2023067) for WES analyses. A.K. acknowledges funding by the European Union’s ERA fellowship (2D-TOPMASS, grant 101090276). The work was further supported by the grants from the Spanish Ministry of Science and Innovation PID2021-128087OB-I00 by MCIN /AEI /10.13039/501100011033 / FEDER, UE to M.J.B, Fundación Inocente grant number FII2024-125 and grant AESI PT20CIII/00009 (ISCIII Platform of Biobanks and Biomodels PT-20/23) from the Spanish National Institute of Health Carlos III. Funding was also partially provided by the Genome Canada and the Ontario Genomics Institute Genomics Applications Partnership Program Grant (OGI-188). Several co-authors are also members of the European Reference Network ITHACA. We further acknowledge the Solve-RD project, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 779257.We further acknowledge CMS-Biocev (“Biophysical techniques, Crystallization, Diffraction, Structural mass spectrometry”) of CIISB, Instruct-CZ Center, supported by MEYS CR (LM2023042) and European Regional Development Fund-Project „UP CIISB“ (No. CZ.02.1.01/0.0/0.0/18_046/0015974). This study used tools provided through the RD-Connect GPAP, which received funding originally from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement No. 305444. This study has also been delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Center (NIHR203308). S.B. acknowledges the support of the MRC Epigenomics of Rare Diseases (EpiGenRare) Node (MR/Y008170/1). D.J. acknowledges the financial support from the Ministry of Health of the Czech Republic (MH CZ-DRO, Institute for Clinical and Experimental Medicine IKEM, IN 00023001). | |
| dc.format.number | 1 | |
| dc.format.volume | 17 | |
| dc.identifier.citation | Hnízda, A., Martinez-Delgado, B., Sanchez-Ponce, D. et al. De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity. Nat Commun 17, 8203 (2026). https://doi.org/10.1038/s41467-026-74987-w. | |
| dc.identifier.doi | 10.1038/s41467-026-74987-w | |
| dc.identifier.e-issn | 2041-1723 | |
| dc.identifier.journal | Nature communications | |
| dc.identifier.pubmedID | 42386776 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/27798 | |
| dc.language.iso | eng | |
| dc.publisher | Springer Nature | |
| dc.relation.isbasedon | https://proteomecentral.proteomexchange.org/ui?pxid=PXD079241 | |
| dc.relation.isbasedon | https://ega-archive.org/studies/EGAS50000001637 | |
| dc.relation.isbasedon | https://doi.org/10.5281/zenodo.19630380 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-128087OB-I00/ES/MOLELOS Y MECANISMOS EN ENFERMEDADES ULTRA RARAS CON BASE EPIGENETICA/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI-FEDER//501100011033/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Fundación Inocente//FII2024-125/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/AESI/PT20CIII%2F00009/// | |
| dc.relation.publisherversion | https://doi.org/10.1038/s41467-026-74987-w | |
| dc.repisalud.centro | ISCIII::Instituto de Investigación de Enfermedades Raras (IIER) | |
| dc.repisalud.institucion | ISCIII | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Chromosome Deletion | |
| dc.subject.mesh | Chromosomes, Human, Pair 9 | |
| dc.subject.mesh | Craniofacial Abnormalities | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Hand Deformities, Congenital | |
| dc.subject.mesh | Haploinsufficiency | |
| dc.subject.mesh | Heart Defects, Congenital | |
| dc.subject.mesh | Histocompatibility Antigens | |
| dc.subject.mesh | Histone-Lysine N-Methyltransferase | |
| dc.subject.mesh | Histones | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Intellectual Disability | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Mice | |
| dc.title | De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 1ddea53d-8bbc-4196-82a6-1f6b8ea3a92b | |
| relation.isAuthorOfPublication | b0355d3e-36ca-4aab-a60a-9cf49c62bda4 | |
| relation.isAuthorOfPublication | 7416f724-f758-4723-8e95-ca2ff70ee53c | |
| relation.isAuthorOfPublication | 16ca30ec-854c-4770-931e-e7d9ea71369a | |
| relation.isAuthorOfPublication | 5764d316-caf4-47a6-b03f-4cfdc5b2e892 | |
| relation.isAuthorOfPublication | 9b9ff7e4-de3b-439a-b53a-dd659936a88c | |
| relation.isAuthorOfPublication | d0ee7849-1683-4c6e-b977-2a93cf579641 | |
| relation.isAuthorOfPublication | d8e72207-5535-4159-833e-6d203a600e90 | |
| relation.isAuthorOfPublication | 7c941dce-7293-4477-b341-511263e217e9 | |
| relation.isAuthorOfPublication | 6db924bf-24e0-4299-8c78-50337deed109 | |
| relation.isAuthorOfPublication | c474ba31-7f20-4966-a77e-34f9bf4f3602 | |
| relation.isAuthorOfPublication | 75b3e5cf-ce99-4092-a6b0-8ba38b493bd8 | |
| relation.isAuthorOfPublication.latestForDiscovery | 1ddea53d-8bbc-4196-82a6-1f6b8ea3a92b | |
| relation.isFunderOfPublication | 639cecfa-9455-4e7f-9f65-9ece17a878f0 | |
| relation.isFunderOfPublication | 77207b4b-da6c-45c7-80ac-ea685be4b26b | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | 1aef4c3b-1ee5-4534-83b4-3f3811c67280 | |
| relation.isFunderOfPublication.latestForDiscovery | 639cecfa-9455-4e7f-9f65-9ece17a878f0 | |
| relation.isPublisherOfPublication | b35c2080-c7d1-4e7c-95ea-1d4c7d394078 | |
| relation.isPublisherOfPublication.latestForDiscovery | b35c2080-c7d1-4e7c-95ea-1d4c7d394078 |


